- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Exenatide – July 2011
Exenatide, powder for injection, 2 mg, Bydureon®
Last updated
20 May 2013